This has led to the development of GLP-1 receptor agonists (GLP-1 RAs), which have demonstrated favourable effects not only on metabolic variables but also on cardiovascular endpoints [4,5,6]
However, for inflammatory factors, since there were no changes in gene expression due to the drug treatment, protein levels were not measured
Post-surgery, appetite-regulating hormones such as GLP-1 and PYY naturally increase, while ghrelinthe hunger hormonedecreases
[5] [1] The precise incidence of belching as an isolated symptom in patients taking Ozempic has been documented in clinical trials
Understanding what blood tests monitor during GLP-1 therapy helps patients navigate treatment confidently and communicate effectively with their healthcare providers
We increase the dose slowly to allow our body to adjust